Comparison of 18F-FET and 18F-FDG PET in brain tumors

Nuclear Medicine and Biology

Volumn 36, Issue 7, 2009, Pages 779-787

  Pauleit, Dirk ^a   Stoffels, Gabriele ^a   Bachofner, Ansgar ^b   Floeth, Frank W ^b   Sabel, Michael ^b   Herzog, Hans ^a   Tellmann, Lutz ^a   Jansen, Paul ^a   Reifenberger, Guido ^b   Hamacher, Kurt ^a   Coenen, Heinz H ^a   Langen, Karl Josef ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

18F FDG; 18F fluoroethyl l tyrosine; Amino acid PET; Cerebral glioma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; O (2 FLUOROETHYL)TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ABSCESS; BRAIN DAMAGE; BRAIN TUMOR; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; GLIOMA; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR BIOPSY; WHITE MATTER;

ADOLESCENT; AGED; BRAIN NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TYROSINE; YOUNG ADULT;

EID: 69249222584     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.05.005     Document Type: Article

References (35)

1. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 48 (2007) 1468-1481
2. Kaschten B., Stevenaert A., Sadzot B., et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39 (1998) 778-785
3. Goldman S., Levivier M., Pirotte B., et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med 38 (1997) 1459-1462
4. Langleben D.D., and Segall G.M. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41 (2000) 1861-1867
5. Jager P.L., Vaalburg W., Pruim J., et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42 (2001) 432-445
6. 18F]fluoroethyl)-l-tyrosine for tumor imaging. J Nucl Med 40 (1999) 205-212
7. 18F]fluoroethyl)-l-tyrosine. Appl Radiat Isot 57 (2002) 853-856
8. 18F]fluoroethyl)-l-tyrosine PET combined with magnetic resonance imaging improves the diagnostic assessment of cerebral gliomas. Brain 128 (2005) 678-687
9. 18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31 (2004) 1464-1470
10. 18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57 (2005) 505-511
11. 18F-fluoroethyl)-l-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48 (2007) 519-527
12. 18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33 (2006) 287-294
13. Chung J.K., Kim Y.K., Kim S.K., et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29 (2002) 176-182
14. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45 (2004) 1293-1298
15. 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 32 (2005) 39-51
16. Weber W., Bartenstein P., Gross M.W., et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 38 (1997) 802-808
17. 18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 26 (1999) 144-151
18. Henze M., Mohammed A., Schlemmer H.P., et al. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis. J Nucl Med 45 (2004) 579-586
19. Kleihues P., and Cavenee W.K. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system (2000), IARC Press, Lyon, France
20. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 (2007) 97-109
21. 18F]fluoroethyl-l-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102 (2005) 318-327
22. 18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 (1986) 235-238
23. Pöpperl G., Kreth F.W., Mehrkens J.H., et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 34 (2007) 1933-1942
24. Meyer P.T., Schreckenberger M., Spetzger U., et al. Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses. Eur J Nucl Med 28 (2001) 165-174
25. Chen W., Silverman D.H., Delaloye S., et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47 (2006) 904-911
26. Grosu A.L., Weber W.A., Franz M., et al. Reirradiation of recurrent high-grade gliomas using amino acid PET(SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 511-519
27. Ceyssens S., Van Laere K., de Groot T., et al. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 27 (2006) 1432-1437
28. 123I]Iodo-α-methyl-l-tyrosine uptake in cerebral gliomas: relationship to histopathological grading and prognosis. Eur J Nucl Med 28 (2001) 855-861
29. Kaim A.H., Weber B., Kurrer M.O., et al. (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med 29 (2002) 648-654
30. 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 45 (2004) 1931-1938
31. Floeth F.W., Pauleit D., Sabel M., et al. Differentiation of tumorous and non-tumorous ring enhancing lesions (REL) with FET PET. J Nucl Med 47 (2006) 776-782
32. 3H-l-methionine in focal cortical ischemia. Nucl Med Biol 33 (2006) 1029-1035
33. 3H-deoxyglucose in brain abscesses. J Nucl Med 48 (2007) 2056-2062
34. 18F]fluorethyl)-l-tyrosine PET in the clinical evaluation of primary brain tumors. Eur J Nucl Med Mol Imaging 32 (2005) 422-429
35. Pöpperl G., Kreth F.W., and Herms J. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?. J Nucl Med 47 (2006) 393-403